- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Standardized template for clinical reporting of PSMA PET/CT scans ; day:15 ; month:8 ; year:2024 ; pages:1-7
European journal of nuclear medicine and molecular imaging ; (15.8.2024), 1-7
- Creator
-
Esfahani, Shadi A.
Morris, Michael J.
Sartor, Oliver
Frydenberg, Mark
Fanti, Stefano
Calais, Jeremie
Vapiwala, Neha
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-024-06857-w
- URN
-
urn:nbn:de:101:1-2411022104176.061029368396
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Esfahani, Shadi A.
- Morris, Michael J.
- Sartor, Oliver
- Frydenberg, Mark
- Fanti, Stefano
- Calais, Jeremie
- Vapiwala, Neha
- SpringerLink (Online service)
Other Objects (12)
![Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens](/assets/placeholder/searchResultMediaUnknown.png)
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on 18F-DCFPyL PET/CT imaging
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on \(^18}\)F-DCFPyL PET/CT Imaging
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Metabolic tumour volume from PSMA PET/CT scans of prostate cancer patients during chemotherapy - do different software solutions deliver comparable results?
Pitfalls in PSMA imaging: [18F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on 18F-DCFPyL PET/CT imaging
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on \(^18}\)F-DCFPyL PET/CT Imaging
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Metabolic tumour volume from PSMA PET/CT scans of prostate cancer patients during chemotherapy - do different software solutions deliver comparable results?
Pitfalls in PSMA imaging: [18F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on 18F-DCFPyL PET/CT imaging
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on \(^18}\)F-DCFPyL PET/CT Imaging
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Metabolic tumour volume from PSMA PET/CT scans of prostate cancer patients during chemotherapy - do different software solutions deliver comparable results?
Pitfalls in PSMA imaging: [18F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy